Whose work led to the first vaccine against meningitis B?
Quick Answer
The MenB vaccine was developed through modern genomics-based research, notably by scientists at Novartis and later GSK, building on the work of multiple researchers rather than a single discoverer. It was first licensed in the 2010s.
The Full Story
Meningitis B was unusually difficult to vaccinate against because its outer surface did not respond well to older vaccine methods. A genomics approach, often called reverse vaccinology, helped identify proteins that could trigger immunity. This work involved researchers at Novartis Vaccines, including Rino Rappuoli’s team. The first MenB vaccine was licensed in the 2010s and marked a major advance in bacterial vaccine design.
Key Facts
YouTube Angle
Suggested video title for this topic:
"The genomics breakthrough that finally made a meningitis B vaccine possible"
Was this answer helpful?
Tap a reaction — it helps us pick what to cover next.